HDIVX
Price
$21.49
Change
-$0.06 (-0.28%)
Updated
Aug 20 closing price
Net Assets
313.65M
HFQRX
Price
$8.36
Change
-$0.00 (-0.00%)
Updated
Aug 20 closing price
Net Assets
7.92B
Interact to see
Advertisement

HDIVX vs HFQRX

HDIVX vs HFQRX Comparison Chart in %
View a ticker or compare two or three
VS
HDIVX vs. HFQRX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HDIVX is a Buy and HFQRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.92B vs. HDIVX (314M). HFQRX pays higher dividends than HDIVX: HFQRX (6.16) vs HDIVX (1.86). HDIVX was incepted earlier than HFQRX: HDIVX (14 years) vs HFQRX (11 years). HDIVX (1.08) is less costly to investors than HFQRX (0.69). HFQRX is a more actively managed with annual turnover of: 175.00 vs. HDIVX (50.00). HDIVX has a lower initial minimum investment than HFQRX: HDIVX (2500) vs HFQRX (1000000). HFQRX annual gain was more profitable for investors over the last year : 26.01 vs. HDIVX (20.10). HFQRX return over 5 years is better than : 79.15 vs. HDIVX (65.79).
HDIVXHFQRXHDIVX / HFQRX
Total Expense Ratio0.870.69126%
Annual Report Gross Expense Ratio1.080.69157%
Fund Existence14 years11 years-
Gain YTD19.18418.519104%
Front LoadN/AN/A-
Min. Initial Investment250010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets314M7.92B4%
Annual Yield % from dividends1.866.1630%
Returns for 1 year20.1026.0177%
Returns for 3 years67.4378.2286%
Returns for 5 years65.7979.1583%
Returns for 10 years133.67131.68102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRIGX32.360.32
+1.00%
Meridian Growth Investor
TQGEX24.400.17
+0.70%
T. Rowe Price Integrated Global Eq
AMAGX106.910.48
+0.45%
Amana Growth Investor
GRMIX34.660.15
+0.43%
Nationwide S&P 500 Index R6
RFIMX8.520.03
+0.35%
Ranger Micro Cap Institutional